10 unknown. 10 Phase 3, 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 10 | Unknown 10 |
| Phase 2 | 5 | Unknown 5 |
Follow Brain Damage, Chronic: new trials by email Literature Review of Brain Damage, Chronic trials Research Report on Brain Damage, Chronic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lateral Cord Magnetic Stimulation For Refractory Spastic Cerebral Palsy Magnetic Spinal Stimulation - Spastic Cerebral Palsy, Dysarthria | Phase 2 / Phase 3 | Unknown | Sociedad Argenttina de Neuromodulación | 20 | 2024-11-18 | 2023-11-21 |
| Efficacy of Extracorporeal Shock Wave Therapy in Children With Cerebral Palsy ESWT, Botulinum Toxin Type A, Serial Casting - Spasticity/Paresis, Cerebral Palsy | Phase 3 | Unknown | Kocaeli University | 40 | 2023-11-01 | 2023-11-18 |
| Magnesium Sulphate Neuroprotective Strategies for Preterm Deliveries Magnesium sulfate loading with maintenance dose, Magnesium sulfate loading dose only - Premature Birth, NEUROPROTECTION | Phase 2 / Phase 3 | Unknown | Zagazig University | 336 | 2023-01-20 | 2023-07-14 |
| Effect of Erythropoietin in Premature Infants on White Matter Lesions and Neurodevelopmental Outcome Erythropoietin, Normal saline - Premature Infants, Intracranial Hemorrhages | Phase 3 | Unknown | First Affiliated Hospital Xi'an Jiaotong University | 400 | 2017-04-10 | 2017-10-02 |
| Two Intensities of Transcranial Direct Current Stimulation to Improve Consciousness in Severely Brain Injured Patients transcranial direct current stimulation (tDCS) / Comparison of current intensities - Disorder of Consciousness, Minimally Conscious State | Phase 3 | Unknown | Groupe Hospitalier Pitie-Salpetriere | 300 | 2017-01-01 | 2017-01-18 |
| Targeted Hip Strength Training in Children With Cerebral Palsy (CP) Usual care plus progresive resistance training - Cerebral Palsy | Phase 3 | Unknown | University of Nottingham | 20 | 2011-12-01 | 2012-07-04 |
| Application of Botulinum Toxin Type A in Salivary Glands in the Treatment of Drooling in Patients With Cerebral Palsy BOTULINUM NEUROTOXIN TYPE-A - Sialorrhea, Cerebral Palsy | Phase 2 / Phase 3 | Unknown | Hospital Vall d'Hebron | 60 | 2011-11-01 | 2012-10-30 |
| Safety and Efficacy of Bone Marrow MNC for the Treatment of Cerebral Palsy in Subjects Below 15 Years Intra thecal inj of autologous MNC - Cerebral Palsy | Phase 2 / Phase 3 | Unknown | Chaitanya Hospital, Pune | 100 | 2011-03-01 | 2014-09-17 |
| Modulation of Brain Plasticity After Perinatal Stroke Repetitive Transcranial Magnetic Stimulation (rTMS), Constraint-induced movement therapy (CIMT) - Stroke, Cerebral Palsy | Phase 2 / Phase 3 | Unknown | University of Calgary | 64 | 2010-08-01 | 2013-10-23 |
| Magnesium Sulfate to Prevent Brain Injury in Premature Infants magnesium sulfate - Brain Injuries, Cerebral Palsy | Phase 3 | Unknown | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 1987-08-01 | 2005-06-24 |
Cerebral Palsy (9) · Intracranial Hemorrhages (2) · Leukomalacia, Periventricular (2) · Muscle Spasticity (2) · Premature Birth (2) · Brain Injuries (1) · Cognitive Dysfunction (1) · Consciousness Disorders (1) · Dysarthria (1) · Intellectual Disability (1) · Ischemic Stroke (1) · Paresis (1) · Perinatal Death (1) · Persistent Vegetative State (1) · Sialorrhea (1)
Brain Diseases (10) · Central Nervous System Diseases (10) · Nervous System Diseases (10) · Pathological Conditions, Signs and Symptoms (6) · Neurologic Manifestations (4) · Signs and Symptoms (4) · Cardiovascular Diseases (3) · Cerebrovascular Disorders (3) · Neurobehavioral Manifestations (3) · Pathologic Processes (3) · Vascular Diseases (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Encephalomalacia (2) · Female Urogenital Diseases and Pregnancy Complications (2)
Botulinum Toxins, Type A (2) · Constraint Induced Movement Therapy (1) · Erythropoietin (1) · Magnesium Sulfate (1) · Occupational Therapy (1) · Physical Therapy Modalities (1) · Resistance Training (1) · Saline Solution (1) · Short-Wave Therapy (1) · Sodium Chloride (1) · Transcranial Direct Current Stimulation (1) · Transcranial Magnetic Stimulation (1) · Transcutaneous Electric Nerve Stimulation (1) · epoetin beta (1)
Chaitanya Hospital, Pune (1) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · First Affiliated Hospital Xi'an Jiaotong University (1) · Groupe Hospitalier Pitie-Salpetriere (1) · Hospital Vall d'Hebron (1) · Kocaeli University (1) · Sociedad Argenttina de Neuromodulación (1) · University of Calgary (1) · University of Nottingham (1) · Zagazig University (1)
Argentina (1) · Canada (1) · China (1) · Egypt (1) · France (1) · India (1) · Spain (1) · United Kingdom (1) · United States (1)
Adam Kirton, MD MSc FRCPC (1) · Amro Alnemr, M.D. (1) · Anant E Bagul, M.S. (1) · Grahame Pope, MPhil, BSc (1) · Hytham Atia, M.D. (1) · Juan Carlos M Andreani, MD (1) · Lionel Naccache, MD PhD (1) · Mohamed Arafa, M.D. (1) · Mohamed Lashin, M.D. (1) · Nigar Dursun, MD (1) · Sherief M El Gebaly, M.D. (1) · Thomas E. Wiswell, M.D. (1) · Tommaso Tufo, MD (1) · Werner Braunsdorf, MD (1)
PMID 25157725, PMID 25534356, PMID 26812925, PMID 27029628, PMID 27130143, PMID 27187300, PMID 27244862, PMID 27631386, PMID 31691605, PMID 33206382, PMID 33483965, PMID 34828772, PMID 35412036, PMID 36306168, PMID 36832460
R01HD021453 (1)